[Posted by Shirley Richardson]
Biogen Idec officials
say that four more patients have contracted a rare brain infection
associated with the company’s blockbuster multiple sclerosis drug,
Tysabri.
This brings the total number of cases of the infection, known as PML, to 35 since July 2008....read report in The Journal of New England Technology
Labels: Tysabri, Biogen
